Highlights:

• Profitability rebounded sharply, setting a stronger base for the next growth phase.
• Protein-led demand and international expansion could provide fresh momentum through FY2027.
• Major efficiency projects are now positioned to translate investment into meaningful savings.

FY26 Earnings MomentumBega Cheese Limited (ASX: BGA) announced its audited FY2026 results on 20 August 2026, reporting stronger earnings across both its Branded and Bulk operations. Revenue climbed to AU$3.77 billion, while statutory EBITDA reached AU$202.3 million and statutory profit after tax improved to AU$54.8 million from an AU$8.5 million loss in FY2025. Branded and Bulk DeliverNormalised EBITDA increased to AU$225.6 million, supported by gains across both core segments. Branded normalised EBITDA reached AU$220.7 million as yoghurt, milk-based beverages and white milk recorded strong volume growth. International revenue increased 12%, while demand strengthened for high-protein and better-for-you offerings.

Bulk normalised EBITDA rose to AU$53.2 million, benefiting from higher milk intake, improved product mix, stronger nutritional powder sales and greater integration with the Branded portfolio.Investment Supports EfficiencyBega invested AU$109.8 million in capital projects during FY2026, including capacity expansion and logistics improvements. Operating cash flow stood at AU$129.3 million, while net debt increased to AU$151.6 million. Despite higher investment and restructuring expenditure, leverage remained contained at 0.8 times.

The company also declared a fully franked final dividend of 7.5 cents per share, lifting total FY2026 dividends to 14.5 cents.FY27 Outlook BuildsManagement expects normalised EBITDA of AU$240 million–AU$245 million in FY2027, subject to normal trading conditions. The Ridge Street consolidation and Laverton warehouse automation are expected to support approximately AU$38 million of savings during the year.

Beyond FY2027, Bega’s refreshed S31 strategy targets normalised EBITDA above AU$310 million by FY2031. Rising protein demand, further international expansion and efficiency gains could support that ambition, although input-cost pressures and geopolitical volatility remain important variables for the earnings trajectory.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au